Previous diversity workshops have identified disparities in liver disease and liver transplantation, providing insights on solutions to these disparities. This year’s workshop will serve as a bridge between past discussions to approach solutions. Speakers will delve deeply into ways we can identify and apply appropriate research methods to gather the data necessary to address and improve ongoing health disparities.

Non-alcoholic fatty liver disease (NAFLD) is not rare among lean individuals. But in the absence of traditional risk factors, it remains under-recognized. At this JSH-AASLD session, experts unravel the latest data on lean-NASH prevalence in the general population. Speakers will also explore the influence of genetics and environment, and the impact of metabolic abnormalities in fibrosis development in lean-NASH.

Yi‐Ming Lin, Ai‐Yong Cui, Da‐Wei Wang, Hua‐Ding Lu – 14 November 2020

Mussarat N. Rahim, Shaolu Ran, Sital Shah, Sarah Hughes, Michael A. Heneghan – 14 November 2020

Samuel J. Kesseli, Mariya L. Samoylova, John Yerxa, Carrie B. Moore, Marcelo Cerullo, Qimeng Gao, Nader Abraham, Yuval A. Patel, Lisa M. McElroy, Deepak Vikraman, Andrew S. Barbas – 14 November 2020 – Liver grafts from pediatric donors represent a small fraction of grafts transplanted into adult recipients, and their use in adults requires special consideration of donor size to prevent perioperative complications.

Explore timely topics in liver disease in a lively debate format as pediatric and adult/general hepatology trainees and practicing hepatologists tackle important, often controversial issues. Debaters will gain skills in critical thinking, balanced argumentation and factual examination of each issue's pros and cons. Debaters, judges and audience members will grapple with opposing scientific, societal, individual and financial viewpoints on current clinical concerns. 

The Ohio State Wexner Medical Center vs Hospital University of Pennsylvania 

At this year's Thomas E. Starzl lecture, an expert in the field will discuss the most recent developments and controversies concerning living donor liver transplantation. The lecture will encompass topics like the current need for living organ donors, and the balance of donor and recipient risks with benefits for both parties in this life-saving procedure.

This engaging session will explore hot topics in the management of liver cancer, including talks on hepatobiliary neoplasia and liver transplant. The program's first segment will address advancements in research on the pathogenesis and surgical management of liver cancer, while the second half provides analysis of the newest advances in the systemic management of both iCCA and HCC.

The 2020 Hans Popper lecture reviews the cellular and molecular mechanisms of liver regeneration upon toxic injury, and how these mechanisms change in disease, mainly cancer. Learn how one lab combined animal and human organoid models, how to recapitulate key aspects of liver development and regeneration in vitro, and potential applications of these models in personalized medicine.

At this symposium, experts explore current controversies in transplant hepatology. An ethicist sets the stage with a lively discussion of current practices and challenges in patient and organ selection. Questions explored will include strategies to increase the donor pool, including living and altruistic donations, and the role of transplantation in patients with high-risk liver tumors and underlying mitochondrial disease.